#TRANSCENDT2D1 trial : A new era in the treatment of #Type2Diabetes The TRANSCEND-T2D-1 trial provides compelling evidence that #retatrutide, a first-in-class triple GIP/GLP-1/glucagon receptor agonist, may redefine expectations for the treatment of Type 2 DM
GLP-1 receptor agonists slow gastric emptying, meaning food sits in your stomach longer than usual
Final Thoughts: Wegovy, Alcohol, and Your Weight Loss Goals If youre considering Wegovy or already enrolled in a program, understanding alcohols role can make a big difference
An important thing that we have to understand before we dive into all of this is how Tylenol and glutathione are connected
Why researchers choose this stack: Multi-pathway approach to hair follicle research Copper peptidedriven innovation across all components Supports scalp health, density, and growth-phase signaling studies Premium formulations with high-purity standards One stack
GLP-1 fatigue and headaches